Monarin tablets

Dexa Medica

Ingredients in every tablet

Montelukast 10 mg

Each package contains

3 blisters of 10 tablets

Other details

Dosage form:Tablet; coated
Flavour: None

W.H.O. classification

ATC Level 1: R - Respiratory system
ATC Level 2: R03 - Drugs for Obstructive Airway Diseases
ATC Level 3: R03D - Other Systemic Drugs for Obstructive Airway Diseases in ATC

Warnings

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution.

Available in

Indonesia

Dosage information

0 TO 15 YEARS OLD
Montelukast 10 mg tablets should not be prescribed.

15 YEARS OLD AND ABOVE
Asthma
Monarin should be taken once daily in the evening (one-10 mg tablet)

Exercise-Induced Bronchoconstriction (EIB)
For prevention of EIB, a single dose (one-10 mg tablet) of Monarin should be taken at least 2 hours before exercise.
An additional dose of Monarin should not be taken within 24 hours of a previous dose. Patients already taking Monarin daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB. All patients should have available for rescue a short-acting β-agonist. Daily administration of Monarin for the chronic treatment of asthma has not been established to prevent acute episodes of EIB.

The therapeutic effect of montelukast on parameters of asthma control occurs within one day. Montelukast may be taken with or without food. Patients should be advised to continue taking montelukast even if their asthma is under control, as well as during periods of worsening asthma.

RENAL IMPAIRMENT
No dosage adjustment is necessary for patients with renal insufficiency.

HEPATIC IMPAIRMENT
No dosage adjustment is necessary for patients with mild to moderate hepatic impairment.

Indication

Monarin is indicated in Adults for the prophylaxis and chronic treatment of asthma, including the prevention of exercise-induced bronchoconstriction.

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.